- Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer
Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease…
- Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This…
- Stämm definiert die Bioproduktion mit einem blasenfreien Hochdurchsatz-Bioprozessor für die dezentrale Fertigung neu
Die neue Plattform eliminiert hydrodynamische Scherbelastung und skaliert isometrisch von 50 mL bis 250 mL mit dem…
- BioDlink Named “Emerging CDMO of the Year” at the 2026 Asia-Pacific Biopharma Excellence Awards
BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics…
- Pinnacle Food Group Limited Successfully Concludes 2026 Investor Day, Highlighting its “Dual-Engine” Growth Strategy
VANCOUVER, BC, March 13, 2026 /PRNewswire/ — Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven…
- Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy
SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as…
- Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
STATEN ISLAND, N.Y., March 13, 2026 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or…
- SciBase: Interim report
STOCKHOLM, March 13, 2026 /PRNewswire/ — January 1 – December 31, 2025 The fourth quarter…
- WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation
SINGAPORE, March 12, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract…
- PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement
— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining…
- Stämm redéfinit la biofabrication avec un bioprocesseur à haut débit sans bulles conçu pour une production décentralisée
La nouvelle plateforme élimine les contraintes de cisaillement hydrodynamique et s’étend de manière isométrique de…
- ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026
NEW YORK, March 12, 2026 /PRNewswire/ — ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for…
- Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
LEXINGTON, Mass., March 12, 2026 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on…
- Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO, March 12, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for…
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Biologics License Application (BLA) for INO-3107 accepted for review under the Accelerated Approval Program as…
- Stämm redefine la biofabricación con un bioprocesador diseñado para la producción descentralizada
– Stämm redefine la biofabricación con un bioprocesador de alto rendimiento y sin burbujas diseñado para…
- Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders
World-renowned clinician-scientist to chair, lead new department MEMPHIS, Tenn., March 12, 2026 /PRNewswire/ — St. Jude Children’s…
- Rosalind Franklin University Doubles Helix 51 Incubator
Fueling the next wave of bioinnovation: Helix 51 scales up as regional launchpad NORTH CHICAGO,…
- IDBS Wins Best Biologics Digitalisation: Software Innovation Award, at the 2026 Asia Pacific Biopharma Excellence Awards
WOKING, United Kingdom, March 12, 2026 /PRNewswire/ — IDBS, a leading provider of cloud software…
- Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
SAN JOSE, Calif., March 12, 2026 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ:…
Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease…
Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This…
BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics…
VANCOUVER, BC, March 13, 2026 /PRNewswire/ — Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven…
SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as…
STATEN ISLAND, N.Y., March 13, 2026 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or…
STOCKHOLM, March 13, 2026 /PRNewswire/ — January 1 – December 31, 2025 The fourth quarter…
SINGAPORE, March 12, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract…
— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining…
NEW YORK, March 12, 2026 /PRNewswire/ — ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for…
LEXINGTON, Mass., March 12, 2026 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on…
SAN FRANCISCO, March 12, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for…
Biologics License Application (BLA) for INO-3107 accepted for review under the Accelerated Approval Program as…
World-renowned clinician-scientist to chair, lead new department MEMPHIS, Tenn., March 12, 2026 /PRNewswire/ — St. Jude Children’s…
Fueling the next wave of bioinnovation: Helix 51 scales up as regional launchpad NORTH CHICAGO,…
WOKING, United Kingdom, March 12, 2026 /PRNewswire/ — IDBS, a leading provider of cloud software…
SAN JOSE, Calif., March 12, 2026 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ:…